Comparison of two laser power levels in the subthreshold MicroPulse Yellow Laser Treatment of Acute Central Serous Chorioretinopathy

Liru Qin,Daming Li,Yuzhe Zhou,Han Zhang,Guisen Zhang,Xiurong Zhang,Wei Shi
DOI: https://doi.org/10.1016/j.pdpdt.2024.104323
IF: 3.577
2024-09-01
Photodiagnosis and Photodynamic Therapy
Abstract:Aims To compare the efficacy of two power levels in the 577 nm sub-threshold micro pulse laser (SML) treatment of acute central serous chorioretinopathy (aCSC). Methods A retrospective comparative study was conducted. A total of 65 patients (65 eyes) with aCSC were enrolled. Of which, 32 patients received low power treatment and 33 patients received high power treatment of 577-nm SML. Best-corrected visual acuity (BCVA), central macular thickness (CMT), fundus-monitored microperimetry and height of subfoveal choroidal thickness (SFCT) as well as subretinal fluid (SRF) were evaluated at baseline and 3 months. Results The height of SFCT and retinal sensitivity in the low power treatment group was significantly better than that in the high power treatment group at 4 weeks (all p 0.05). In the low power group, the CMT decreased from 379.76 ± 139.23 μm at baseline to 176.56 ± 37.78 μm at 3 months, and in the high power group, the CMT decreased from 364.97 ± 143.08 at baseline to 191.77 ± 38.26 μm at 3 months. There was no significant difference at 3 months between the two groups (p > 0.05). Similar results were also found in term of SRF. Conclusions Timely intervention with 577 nm SML with low power treatment can improve visual acuity, and included anatomic success without adverse events.
oncology
What problem does this paper attempt to address?